Radiation Oncology/Therapy: Page 200

Malpositioned APBI catheter linked to cancer recurrence

By AuntMinnie.com staff writers

Accelerated partial-breast irradiation (APBI) is proving to be an effective treatment for qualified patients with early-stage breast cancer, but precise placement of the balloon catheter is imperative. A case of local recurrence believed to be caused by a malpositioned catheter was recently presented in the Breast Journal.

December 26, 2012

MRI helpful but not perfect for evaluating pancreatic cancer

By Wayne Forrest

Understanding how contrast-enhanced MRI underestimates tumor size compared to pathologic specimens may allow more precise assessment of tumor volume prior to radiation therapy for pancreatic cancer, according to researchers from Emory University.

December 26, 2012

IBA inks deal for Texas proton therapy install

By AuntMinnie.com staff writers

Radiopharmaceutical provider Ion Beam Applications has signed an agreement to install a multiroom proton therapy system at Texas Proton Therapy Center in Las Colinas, TX.

December 20, 2012

Theragenics signs brachytherapy services deal with Oncura

By AuntMinnie.com staff writers

Brachytherapy seed manufacturer Theragenics has finalized a three-year agreement to provide worldwide brachytherapy loading services to cancer treatment product company Oncura, a unit of GE Healthcare.

December 20, 2012

FDG-PET/CT shines in assessing distant cancers

By Wayne Forrest

Whole-body FDG-PET/CT offers "excellent diagnostic performance" in the assessment of distant malignancies in patients with head and neck, breast, and lung cancers, according to a new study in the Journal of Nuclear Medicine.

December 20, 2012

ECRI publishes report on APBI to treat breast cancer

By AuntMinnie.com staff writers

Nonprofit technology research firm ECRI Institute has published a report on the use of accelerated partial-breast irradiation (APBI) using intracavitary brachytherapy as a treatment for early-stage breast cancer.

December 19, 2012

Report: U.S. therapeutic radiopharma market set for growth

By Wayne Forrest

Fueled by new radiopharmaceuticals to treat various forms of cancer, U.S. sales of therapeutic radiopharmaceuticals over the next several years could reach $5.8 billion by 2020, according to a new market research report from Bio-Tech Systems.

December 19, 2012

Varian wins Brazilian TrueBeam contract

By AuntMinnie.com staff writers

Radiation therapy firm Varian Medical Systems has won a contract with a Brazilian hospital for its TrueBeam advanced radiotherapy treatment system.

December 18, 2012

Elekta touts New Zealand installation

By AuntMinnie.com staff writers

Radiation oncology firm Elekta announced that Auckland Radiation Oncology Centre in New Zealand launched its stereotactic radiotherapy program in November, using Elekta's Synergy system upgraded with its Agility technology.

December 18, 2012

Chartrounds offers expert advice to radiation oncologists

By Cynthia E. Keen

Where can radiation oncologists working in community hospitals get advice or feedback about a treatment plan for a patient? If they have an Internet connection, they can join Chartrounds, a virtual networking site that links radiation therapy luminaries with any practicing radiation oncologist in the world.

December 18, 2012

Accuray installs 1st CyberKnife in Venezuela

By AuntMinnie.com staff writers

Radiation oncology firm Accuray announced that Hospital Dr. Domingo Luciani in Caracas is the first hospital in Venezuela to use its CyberKnife robotic radiosurgery system.

December 17, 2012

Is proton therapy worth the cost for prostate cancer?

By Cynthia E. Keen

Is the use of proton therapy for localized prostate cancer worth the cost? A national study of 30,000 men suggests it might not be. Findings were published online December 14 in the Journal of the National Cancer Institute.

December 16, 2012

Previous Page

Page 200 of 468

Next Page